Skip to content
Home
View Investor Deck
News & Events
In the Media
Press Releases
Company Events
Corporate Governance
Management Team
Board of Directors
Governance Documents
Financials
Sedar Filings
Financial Reports
Resources
Shareholder Meetings
Email Alerts
FAQ
EN
FR
Menu
Home
View Investor Deck
News & Events
In the Media
Press Releases
Company Events
Corporate Governance
Management Team
Board of Directors
Governance Documents
Financials
Sedar Filings
Financial Reports
Resources
Shareholder Meetings
Email Alerts
FAQ
EN
FR
Financial Reports
2024 Financial Reports
2024 Financial Statements
24Q1
24Q2
24Q3
24Q4
Consolidated Financial Statements
Management Discussion and Analysis
2025 Annual Information Form
2023 Financial Reports
2023 Financial Statements
23Q1
23Q2
23Q3
23Q4
Consolidated Financial Statements
Management Discussion and Analysis
2022 Financial Reports
2022 Financial Statements
22Q1
22Q2
22Q3
22Q4
Consolidated Financial Statements
Management Discussion and Analysis
2021 Financial Reports
2021 Financial Statements
21Q1
21Q2
21Q3
21Q4
Consolidated Financial Statements
Management Discussion and Analysis
2020 Financial Reports
2020 Financial Statements
20Q1
20Q2
20Q3
20Q4
Consolidated Financial Statements
Management Discussion and Analysis
2019 Financial Reports
2019 Financial Statements
19Q1
19Q2
19Q3
19Q4
Consolidated Financial Statements
—
Management Discussion and Analysis
—
Welcome to Cannara Biotech Inc.
Please verify your age before entering our site.
Day
Month
Year
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Nova Scotia
Northwest Territories
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Remember me for 30 days?
Submit